The Impact of Medicaid Preferred Drug Lists on Utilization and Costs of Antipsychotic Medication
**Background:** Few studies have attempted to assess the effectiveness of formulary management in reducing the antipsychotic costs and utilization across U.S. state Medicaid programs, despite concerns about the potential impact of such formulary management on Medicaid patient health outcomes. **Obj...
Saved in:
Main Authors: | Christian Frois, Thomas O’Connell, Jacqueline Pesa, John Fastenau |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2013-05-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/9853 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Follow-up Care among Medicaid Patients with Schizophrenia treated with Antipsychotics in the Inpatient Setting
by: Amanda M. Farr, et al.
Published: (2014-10-01) -
Medicaid Eligibility and Time to Re-incarceration Among Previously Incarcerated Subjects With Schizophrenia
by: Chris Kozma, et al.
Published: (2016-10-01) -
Drug utilization study of mood stabilizers and antipsychotics drugs among bipolar disorder patients
by: Lolita Lolita, et al.
Published: (2024-01-01) -
Therapeutic drug monitoring of atypical antipsychotic drugs
by: Grundmann Milan, et al.
Published: (2014-12-01) -
Implementation of carceral medicaid suspension and enrollment programs: perspectives of carceral and medicaid leaders
by: Sachini Bandara, et al.
Published: (2025-01-01)